THE PARKINSON’S AND ALZHEIMER DISEASES
Most common neurodegenerative disorders are Alzheimer's disease (AD) and Parkinson's disease (PD), which afflict millions of people and cost the US economy billions of dollars annually. The scientific community has made great strides in creating therapies that address the symptoms of these two disorders, but has not yet succeeded in curing, inhibiting, or even significantly slowing neurodegeneration. Incase of Parkinson’s disorder, Movement and motor control depend heavily on dopamine, a fundamental neurotransmitter that carries data between neurons. It is difficult for the brain to coordinate muscle actions when dopamine is absent. Patients with Alzheimer's disease may be more likely to experience cognitive impairment, with functional impairments appearing as the disease progresses.